Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret Stock

Equities

ANGEN

TREANGN00028

Biotechnology & Medical Research

Delayed Borsa Istanbul 03:43:02 2024-06-10 am EDT 5-day change 1st Jan Change
11.8 TRY -1.50% Intraday chart for Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret -2.41% -5.54%
Sales 2022 269M 8.31M Sales 2023 238M 7.36M Capitalization 2.74B 84.66M
Net income 2022 330M 10.2M Net income 2023 -137M -4.23M EV / Sales 2022 16.1 x
Net cash position 2022 411M 12.71M Net cash position 2023 336M 10.38M EV / Sales 2023 10.1 x
P/E ratio 2022
14.3 x
P/E ratio 2023
-20 x
Employees 171
Yield 2022
2.76%
Yield 2023
-
Free-Float 25.33%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.84%
1 week-2.41%
Current month-2.08%
1 month-14.10%
3 months-13.34%
6 months-12.17%
Current year-5.54%
More quotes
1 week
11.72
Extreme 11.72
12.82
1 month
11.72
Extreme 11.72
13.60
Current year
11.72
Extreme 11.72
14.93
1 year
11.52
Extreme 11.52
21.76
3 years
9.23
Extreme 9.23
25.03
5 years
9.23
Extreme 9.23
25.03
10 years
9.23
Extreme 9.23
25.03
More quotes
Managers TitleAgeSince
Founder 49 10-06-10
Chief Executive Officer 54 10-06-10
Director of Finance/CFO 37 20-11-30
Members of the board TitleAgeSince
Chief Executive Officer 54 10-06-10
Founder 49 10-06-10
Director of Finance/CFO 37 20-11-30
More insiders
Date Price Change Volume
24-06-10 11.8 -1.50% 361 521
24-06-07 11.98 -2.04% 1,822,204
24-06-06 12.23 -0.24% 3,877,914
24-06-05 12.26 +0.49% 3,564,620
24-06-04 12.2 +1.24% 1,353,066

Delayed Quote Borsa Istanbul, June 10, 2024 at 03:43 am EDT

More quotes
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS is a Turkey-based company, which is s a biotechnology company operating in accordance with ISO 9001, ISO 13485 and 98/79/EC Total Quality Systems. The Company's main activities are to develop and produce Real-Time Polymerase Chain Reaction (Real-Time PCR) kits, and to create a complete solution with automatic nucleic acid isolation devices and Real-Time PCR Systems. The main goals of the entity are to reduce Turkey's foreign dependency in molecular diagnostics and biotechnology and to gain success in the global market by developing and producing molecular genetic products.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
11.98 TRY
Average target price
15.4 TRY
Spread / Average Target
+28.55%
Consensus